News Author: Neil Osterweil Publish date: July 12, 2016
Key clinical point: ATRA-ATO was superior to ATRA-chemotherapy as first-line therapy for acute promyelocytic leukemia.
Major finding: Event-free s...
News Author: Neil Osterweil Publish date: July 11, 2016
Key clinical point: Cabozantinib did not improve overall survival of previously treated metastatic castration-resistant prostate cancer, compared ...
News Author: Neil Osterweil Publish date: July 11, 2016
Key clinical point: Mesenchymal stromal cell infusions may reduce risk of chronic graft-versus-host disease following allogeneic stem cell transpl...
News Author: Neil Osterweil Publish date: July 9, 2016
Key clinical point: Long-term observation of clinical trial patients revealed a dwindling of initial survival benefit from radiation added to chem...
News Author: Neil Osterweil Publish date: July 8, 2016
Key clinical point: Germline mutations in DNA repair genes are potential targets for therapy in men with metastatic prostate cancer.
Major finding...
News Author: Neil Osterweil Publish date: July 8, 2016
Key clinical point: Bendamustine in combination chemotherapy produces high response rates in relapsed refractory Hodgkin lymphoma (HL).
Major find...
News Author: Neil Osterweil Publish date: July 6, 2016
Key clinical point: Two neoadjuvant therapy combinations – one for triple negative breast cancer and one for HER2-positive breast cancer &nd...
News Author: Neil Osterweil Publish date: June 30, 2016
Key clinical point: Clinicians may wish to discuss the option of hysterectomy at the time of salpingo-oophorectomy in women with deleterious BRCA1...
News Author: Neil Osterweil Publish date: June 16, 2016
Key clinical point:.
News Author: Neil Osterweil Publish date: June 16, 2016
COPENHAGEN – It’s early days yet, but results look highly promising for the ability of an experimental gene-transfer therapy to improve coagulation...
News Author: Neil Osterweil Publish date: June 16, 2016
COPENHAGEN – Young adults with acute lymphoblastic leukemia do better when they are treated like children – that is, with a standard pediatric chemoth...
News Author: Neil Osterweil Publish date: June 15, 2016
Key clinical point:.Tyrosine kinase inhibitor therapy can be safely stopped and resumed in many patients with chronic-phase chronic myeloid leukem...
News Author: Neil Osterweil Publish date: June 15, 2016
The anti-CD38 monoclonal antibody daratumumab added to lenalidomide/dexamethasone improved progression-free survival in relapsed/refractory multiple m...
News Author: Neil Osterweil Publish date: June 15, 2016
Key clinical point: Single-agent blinatumomab nearly doubled overall survival compared to chemotherapy in relapsed/refractory ALL.
Major finding: ...
News Author: Neil Osterweil Publish date: June 12, 2016
Among older adults with acute myeloid leukemia, the combination of a drug-antibody conjugate and hypomethylating therapy was associated with high comp...
